title: PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
authors: E
authors: E
authors: Coyaud
authors: S
authors: S
authors: Struski
authors: N
authors: N
authors: Dastugue
authors: P
authors: P
authors: Brousset
authors: C
authors: C
authors: Broccardo
authors: J
authors: J
authors: Bradtke
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood / Q000235:genetics*; D001772:Blood Cell Count; D002675:Child, Preschool; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics*; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics*; D003598:Cytoskeletal Proteins; D005260:Female; D006801:Humans; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D051757:PAX5 Transcription Factor / Q000235:genetics*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000145:classification* / Q000235:genetics* / Q000628:therapy; D011506:Proteins / Q000235:genetics*; D014157:Transcription Factors; D014178:Translocation, Genetic / Q000235:genetics*
chemical_list: C554283:AUTS2 protein, human; D014408:Biomarkers, Tumor; D003598:Cytoskeletal Proteins; D015514:Oncogene Proteins, Fusion; D051757:PAX5 Transcription Factor; C497281:PAX5 protein, human; C554284:PAX5-AUTS2 fusion protein, human; D011506:Proteins; D014157:Transcription Factors